ImmunityBio
IBRX
#4339
Rank
โ‚น164.51 B
Marketcap
โ‚น225.31
Share price
-6.36%
Change (1 day)
-34.83%
Change (1 year)

Revenue for ImmunityBio (IBRX)

Revenue in 2024 (TTM): โ‚น0.61 Billion

According to ImmunityBio's latest financial reports the company's current revenue (TTM ) is โ‚น0.62 Billion. In 2023 the company made a revenue of โ‚น51.78 Million an increase over the revenue in the year 2022 that were of โ‚น19.86 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ImmunityBio from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น0.61 B1084.54%
2023 โ‚น51.78 M160.73%
2022 โ‚น19.86 M-71.43%
2021 โ‚น69.51 M57.12%
2020 โ‚น44.24 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA